Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 SEK | +0.85% | 0.00% | +49.69% |
Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Oct. 26 | Arcoma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Sales 2023 | 163M 15.29M | Sales 2024 * | 179M 16.79M | Capitalization | 156M 14.59M |
---|---|---|---|---|---|
Net income 2023 | 2M 188K | Net income 2024 * | 9M 844K | EV / Sales 2023 | 0.64 x |
Net Debt 2023 | 1.13M 106K | Net cash position 2024 * | 5M 469K | EV / Sales 2024 * | 0.84 x |
P/E ratio 2023 |
41.8
x | P/E ratio 2024 * |
1.69
x | Employees | 32 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 53.16% |
1 day | +0.85% | ||
1 month | +3.48% | ||
3 months | +52.56% | ||
6 months | +68.79% | ||
Current year | +49.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 21-12-31 | |
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 21-12-31 |
Chief Operating Officer | 57 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | - | |
Director/Board Member | 53 | 10-02-28 | |
Lars Kvarnhem
CHM | Chairman | 52 | 16-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11.9 | +0.85% | 12 295 |
24-03-27 | 11.8 | -0.84% | 22,551 |
24-03-26 | 11.9 | +1.71% | 38,141 |
24-03-25 | 11.7 | -1.68% | 31,731 |
24-03-22 | 11.9 | 0.00% | 42,883 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:54 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.69% | 14.65M | |
-3.29% | 15.11B | |
-32.18% | 3.11B | |
-18.18% | 2.31B | |
-14.64% | 1.42B | |
+68.21% | 458M | |
+6.11% | 195M | |
-21.83% | 181M | |
-.--% | 171M | |
-32.78% | 167M |